Target intelligence / Profile preview

Clostridioides difficile suppression via competitive exclusion by defined commensal bacteria

Molecular classification
Other (microbial ecological function), Mechanistic class of colonization resistance
01

Overview

The suppression of *Clostridioides difficile* via competitive exclusion by defined commensal bacteria refers to the prevention of *C. difficile* colonization or infection in the gut by restoring or introducing specific beneficial commensal bacteria. These bacteria prevent *C. difficile* overgrowth by competing for nutrients, producing inhibitory metabolites (such as secondary bile acids), occupying ecological niches, stimulating host immune responses, and in some cases directly neutralizing toxins. Therapeutic approaches that exploit this mechanism include fecal microbiota transplantation and administration of defined live bacterial consortia, which aim to reestablish gut colonization resistance disrupted by antibiotics or disease.

Other names
Competitive exclusion of *Clostridioides difficile*Colonization resistance to *Clostridioides difficile*Gut microbiota-mediated *Clostridioides difficile* suppression
02

Mechanism of action

Competitive exclusion of *C. difficile* through nutrient consumption, production of inhibitory metabolites (e.g., secondary bile acids, short-chain fatty acids). Occupation of ecological niches required for *C. difficile* growth. Direct toxin neutralization by secreted bacterial products (e.g., proteolysis of *C. difficile* toxins).

03

Biological functions

Inhibition of pathogen colonizationMaintenance of gut homeostasisPrevention of *C. difficile* infection
04

Disease associations

Infection (specifically prevention of *Clostridioides difficile* infection (CDI))Other (modulation of gut microbiota as strategy for infectious disease prevention)
05

Safety considerations

Risk of introducing opportunistic pathogens with live microbial therapeuticsPotential disturbance of existing microbiotaVariable efficacy due to interindividual differences in microbiome compositionSafety of defined microbial consortia versus whole FMT
06

Interacting drugs

Fecal microbiota transplant (FMT)

1 more in the full profile.

07

Biomarkers

Relative abundance of key commensal bacterial taxa (e.g., *Clostridium scindens*, *Roseburia intestinalis*)Presence of bile acid metabolic activity (conversion of primary to secondary bile acids)Reduced levels of pathogenic *C. difficile* or toxin detection in stool

Beyond the preview

Go deeper on Clostridioides difficile suppression via competitive exclusion by defined commensal bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile suppression via competitive exclusion by defined commensal bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call